Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Short Interest Up 148.8% in December

Sol-Gel Technologies Ltd. (NASDAQ:SLGL) was the recipient of a large growth in short interest in the month of December. As of December 31st, there was short interest totalling 220,700 shares, a growth of 148.8% from the December 15th total of 88,700 shares. Based on an average daily volume of 470,100 shares, the short-interest ratio is presently 0.5 days. Currently, 3.1% of the shares of the company are short sold.

Sol-Gel Technologies Stock Down 6.7 %

Shares of SLGL traded down $0.09 during mid-day trading on Thursday, hitting $1.21. 132,815 shares of the company’s stock were exchanged, compared to its average volume of 564,422. The firm has a market cap of $33.80 million, a price-to-earnings ratio of -3.57 and a beta of 1.34. The stock’s 50-day simple moving average is $0.75 and its 200-day simple moving average is $0.68. Sol-Gel Technologies has a 52 week low of $0.33 and a 52 week high of $1.65.

Sol-Gel Technologies Company Profile

Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc, develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea.